Methotrexate therapy for Crohns disease: long-term efficacy and safety (2003)
Hommes, DW, Van Den Brande, Joke; U0042234, Stokkers, P, De Ley, Marc; U0007806, Van Deventer, S
Hampe, J, Schreiber, S, Shaw, S H, Lau, K F, Bridger, S, Macpherson, A J, ...
Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, typically starting in early adulthood. IBD is subdivided into two subtypes, on the basis of clinical...
Hampe, J, Schreiber, S, Shaw, S H, Lau, K F, Bridger, S, Macpherson, A J, ...
Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, typically starting in early adulthood. IBD is subdivided into two subtypes, on the basis of clinical...
Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
De Jong, R, Stokkers, P, Lamme, E, Kool, J M, Borst, F, Brouwer, M, ...
It was analysed to what extent the functional T-cell responses that result from T-cell receptor (TcR)/CD3 triggering differ from responses that are induced after simultaneous ligation of CD2 and CD28...
Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease
Stokkers, P, Van Aken, B E, Basoski, N, Reitsma, P, Tytgat, G
Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis
Stokkers, P, Reitsma, P, Tytgat, G
BACKGROUND—Susceptibility to inflammatory bowel disease (IBD) is partially genetically determined and the HLA class II genes are candidates for a role in genetic susceptibility to IBD, because...
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease
Hampe, J, Lynch, N, Daniels, S, Bridger, S, Macpherson, A, Stokkers, P, ...
BACKGROUND AND AIMS—Genetic predisposition for inflammatory bowel disease (IBD) has been demonstrated by epidemiological and genetic linkage studies. Genetic linkage of IBD to chromosome 3 has...